|
Volumn 21, Issue 5, 2007, Pages 698-699
|
Cutaneous pemphigus vulgaris [13]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COMPLEMENT COMPONENT C3;
CYCLOPHOSPHAMIDE;
DAPSONE;
IMMUNOGLOBULIN G;
PEMPHIGUS ANTIBODY;
PREDNISONE;
ACANTHOLYSIS;
ADULT;
BULLOUS SKIN DISEASE;
CASE REPORT;
DISEASE COURSE;
DRUG DOSE REDUCTION;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LETTER;
ORAL BLISTER;
PEMPHIGUS FOLIACEUS;
PEMPHIGUS VULGARIS;
PRIORITY JOURNAL;
REMISSION;
ANTI-INFLAMMATORY AGENTS;
CYCLOPHOSPHAMIDE;
DAPSONE;
DIAGNOSIS, DIFFERENTIAL;
DRUG THERAPY, COMBINATION;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FLUORESCENT ANTIBODY TECHNIQUE, DIRECT;
HUMANS;
MIDDLE AGED;
PEMPHIGUS;
PREDNISONE;
|
EID: 34250351792
PISSN: 09269959
EISSN: 14683083
Source Type: Journal
DOI: 10.1111/j.1468-3083.2006.01993.x Document Type: Letter |
Times cited : (4)
|
References (6)
|